Sponsor
reMYND
Gaston Geenslaan 1, 3001 Leuven, Belgium
About the sponsor
Remynd’s clinical research is centered on Alzheimer’s disease, with interest in therapeutic strategies aimed at addressing cognitive decline and the underlying neurodegenerative disease process. The sponsor’s trial activity reflects a focus on neurology and central nervous system disorders.
- Neurodegeneration
- Cognitive impairment
- Dementia
Its research portfolio indicates involvement in treatments relevant to memory, executive function, and disease modification within brain health and age-related neurological conditions.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.